Merial appreciates your role as an accredited veterinarian in the
community. You are the primary professional who educates your clients
about rabies. Clients rely on you and your clinic's team to safeguard
their pets, and thus their families against this deadly disease.
Conventional rabies vaccines administered by veterinarians will always
remain the primary method of protecting pets and thereby humans against
RABORAL V-RG® was developed to create a secondary barrier against rabies by immunizing populations of wildlife in their natural environment.
RABORAL V-RG® is a vectored vaccine, utilizing a vaccine-strain of
Vaccinia virus as the live vector. This technology allows delivery of a
thermostable rabies vaccine contained within edible baits over large
In response to regional rabies outbreaks (i.e., the
raccoon strain in the Atlantic east coast and the canine strain in south
Texas) state and federal agencies have successfully used RABORAL V-RG® in regional and state wildlife rabies control programs. In the United
States, RABORAL V-RG® was licensed for use in raccoons in 1997 and for use in coyotes in the year 2002. Prior to licensure by the USDA, the
vaccine was approved for environmental release and a wide range of
safety was demonstrated by testing it in more than 60 non-target animal
species, including primates. It is only available for purchase by governmental agencies involved in rabies control programs.
We would like to take this opportunity to thank you for your efforts
and ask for your continued partnership in providing rabies prevention
information to your community. Your involvement in primary vaccination
of domestic animals, as well as acting as an information source for
wildlife rabies control efforts, is critical to successfully controlling
rabies outbreaks. Please take the time to educate yourself about
RABORAL V-RG® and the wildlife immunization program explained on this
website so you can accurately educate your clients. If you have any
questions after reviewing this site, please Contact Us.